Transitional Living Program
Grants to implement, enhance, and/or support effective strategies for successful transition to sustainable living for runaway and homeless youth ages 16 to under 22 and/or pregnant and parenting youth ages 16 to under 22 and their dependent children. Geographic coverage: Nationwide -- Administration for Children and Families, U.S. Department of Health and Human Services (Source: Children funding opportunities via the Rural Assistance Center)
Source: Children funding opportunities via the Rural Assistance Center - May 15, 2019 Category: Child Development Source Type: funding

BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 Clinical Trial Optional)
Funding Opportunity RFA-HL-20-009 from the NIH Guide for Grants and Contracts. This funding opportunity announcement will supportprojectsto enhance the availability and delivery of safe blood to be used for transfusion in patients from low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (SSA). For example, ensuring that children with malaria or sickle cell disease and pregnant women who suffer from obstetric hemorrhage have access to safe transfusion therapies is of high programmatic interest. BLOODSAFE will support projects that develop and test feasible, effective and sustainable strategies to increase t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2019 Category: Research Source Type: funding

Replication of Programs Proven Effective through Rigorous Evaluation to Reduce Teenage Pregnancy, Behavioral Risk Factors Underlying Teenage Pregnancy, or Other Associated Risk Factors (Tier 1, Phase I)
Funding for projects that replicate programs that have been proven effective through rigorous evaluation to reduce teenage pregnancy, behavioral risk factors underlying teenage pregnancy, or other associated risk factors. Geographic coverage: Nationwide -- Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services (Source: Children funding opportunities via the Rural Assistance Center)
Source: Children funding opportunities via the Rural Assistance Center - March 5, 2019 Category: Child Development Source Type: funding

Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative on-demand, event -driven and long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy, and (HIV/STI) and non-HIV STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 4, 2019 Category: Research Source Type: funding

Understanding the Glycemic Profile of Pregnancy - Clinical Centers (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-18-018 from the NIH Guide for Grants and Contracts. This FOA invites applications for Clinical Centers to carefully characterize the normal course of glycemia over the entire duration of pregnancy and understand the evolution of dysglycemia when it occurs. Clinical Centers will recruit and study pregnant women starting in the first trimester and continuing at least through delivery. A separate FOA (RFA-DK-18-019) will solicit a Biostatistics Research Center. Each Clinical Center applicant will propose a study design and provide detailed information about recruitment capacity. All awardees will f...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 11, 2018 Category: Research Source Type: funding

Understanding the Glycemic Profile of Pregnancy - Biostatistics Research Center (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-18-019 from the NIH Guide for Grants and Contracts. This FOA invites applications for a Biostatistics Research Center to participate in a clinical consortium to carefully characterize the course of glycemia over the entire duration of pregnancy and understand the evolution of dysglycemia when it occurs. A separate FOA (RFA-DK-18-018) invites Clinical Centers to recruit and study pregnant women starting in the first trimester, and continuing at least through delivery. All awardees will form a cooperative research consortium in conjunction with NIDDK to design and implement a uniform protocol. Inf...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 11, 2018 Category: Research Source Type: funding

Understanding the Glycemic Profile of Pregnancy - Clinical Centers (U01 Clinical Trial Not Allowed)
This FOA invites applications for Clinical Centers to carefully characterize the normal course of glycemia over the entire duration of pregnancy and understand the evolution of dysglycemia when it occurs. Clinical Centers will recruit and study pregnant women starting in the first trimester and continuing at least through delivery. A separate FOA (RFA-DK-18-019) will solicit a Biostatistics Research Center. Each Clinical Center applicant will propose a study design and provide detailed information about recruitment capacity. All awardees will form a cooperative research consortium in conjunction with NIDDK to design and im...
Source: NIDDK Funding Opportunities - October 11, 2018 Category: Endocrinology Source Type: funding

Understanding the Glycemic Profile of Pregnancy - Biostatistics Research Center (U01 Clinical Trial Not Allowed)
This FOA invites applications for a Biostatistics Research Center to participate in a clinical consortium to carefully characterize the course of glycemia over the entire duration of pregnancy and understand the evolution of dysglycemia when it occurs. A separate FOA (RFA-DK-18-018) invites Clinical Centers to recruit and study pregnant women starting in the first trimester, and continuing at least through delivery. All awardees will form a cooperative research consortium in conjunction with NIDDK to design and implement a uniform protocol. Information obtained from this study is expected to lead to improved approaches for...
Source: NIDDK Funding Opportunities - October 11, 2018 Category: Endocrinology Source Type: funding

Addressing Opioid Use Disorder in Pregnant Women and New Moms
A prize competition to support innovative solutions to improve access to quality health care, including substance use disorder treatment, recovery, and support services for pregnant women with opioid use disorders, their infants, and families, especially those in rural and geographically isolated areas. Geographic coverage: Nationwide -- Health Resources and Services Administration, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - September 19, 2018 Category: American Health Source Type: funding

Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-884 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications that use novel approaches for the development of safe, real-time, non-invasive (or minimally invasive), in vivo methods to assess the development and function of the human placenta across pregnancy. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 1, 2018 Category: Research Source Type: funding

Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-885 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications that use novel approaches for the development of safe, real-time, non-invasive (or minimally invasive), in vivo methods to assess the development and function of the human placenta across pregnancy. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 1, 2018 Category: Research Source Type: funding

Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Optional)
Funding Opportunity RFA-AI-18-023 from the NIH Guide for Grants and Contracts. This initiative will support research to determine the roles and interactions of immune cells at the maternal-fetal interface throughout pregnancy, including mechanisms of responses to vaccination and infection that protect the fetus and that may influence fetal immune system development. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2018 Category: Research Source Type: funding

Phase I Replicating Programs (Tier 1) Effective in the Promotion of Healthy Adolescence and the Reduction of Teenage Pregnancy and Associated Risk Behaviors
Funding to replicate and scale up one of two programs that include the protective factors shown to be effective in preventing teen pregnancy and/or sexual risk behaviors with youth. Geographic coverage: Nationwide -- Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - May 17, 2018 Category: American Health Source Type: funding

Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)
Funding Opportunity PA-18-776 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications to improve health outcomes for women, infants and children, by stimulating interdisciplinary research focused on maternal nutrition and pre-pregnancy obesity. Maternal health significantly impacts not only the mother but also the intrauterine environment, and subsequently fetal development and the health of the newborn. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 9, 2018 Category: Research Source Type: funding

Request for Information (RFI): Research Specific to Pregnant Women and Lactating Women (PRGLAC)
Notice NOT-HD-18-003 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 15, 2018 Category: Research Source Type: funding

Native Youth and Culture Fund
Grants for projects that focus on youth and incorporate culture and tradition to address social and health issues, such as drug and alcohol abuse, teen pregnancy, and mental health. Geographic coverage: Nationwide -- First Nations Development Institute (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - February 2, 2018 Category: American Health Source Type: funding

South Dakota Tobacco Control Program Tobacco Disparities Grant
Grants for disparities-based tobacco prevention and control activities in South Dakota that are aimed at reducing disparate tobacco use among youth and young adults, American Indians, pregnant women, Medicaid clients, spit tobacco users, and mental health and substance abuse populations. Geographic coverage: South Dakota -- South Dakota Department of Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - February 2, 2018 Category: American Health Source Type: funding

International Research Collaboration on Drug Abuse and Addiction Research (R01, Clinical Trial Optional)
Funding Opportunity PA-18-568 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of NIDA and where feasible should address NIDA's international scientific priority areas (http://www.drugabuse.gov/international/research-pri...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 9, 2018 Category: Research Source Type: funding

Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-531 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. Given that the current emerging evidence from limited research indicates a potentially important role for early-life events and exposures in cancer development, it is necessary to better understand 1) the early-life (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2017 Category: Research Source Type: funding

Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-532 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. Given that the current emerging evidence from limited research indicates a potentially important role for early-life events and exposures in cancer development, it is necessary to better understand 1) the early-life (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2017 Category: Research Source Type: funding

Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-529 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA)is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. Given that the current emerging evidence from limited research indicates a potentially important role for early-life events and exposures in cancer development, it is necessary to better understand 1) the early-life (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2017 Category: Research Source Type: funding

Discovery of Molecular Targets for Pregnancy-Related/Induced Diseases and Development of Therapeutics to Prevent/Treat These Diseases (R01 - Clinical Trial Optional)
Funding Opportunity PAR-18-511 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage grant applications that will identify molecular targets for pregnancy associated/induced disorders and will lead to the development of new safer and more effective medications for use in pregnancy. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 19, 2017 Category: Research Source Type: funding

Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 - Clinical Trial Optional)
Funding Opportunity PAR-18-506 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to repurpose already FDA approved drugs for new neonatal and obstetric indications, in order to overcome the difficulties associated with the traditional development of drugs appropriate for use in neonates and pregnant women and facilitate treatment of these vulnerable populations. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 18, 2017 Category: Research Source Type: funding

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-215 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing dru...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 28, 2017 Category: Research Source Type: funding

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Funding Opportunity PAR-18-214 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing dru...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 28, 2017 Category: Research Source Type: funding

Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42)
Funding Opportunity RFA-HD-18-101 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to invite STTR applications to stimulate new and innovative multipurpose prevention technologies (MPTs) through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women. HIV and unintended pregnancy are two major public health problems affecting young women globally. Combination prevention modalities may be more desirable and lead to better adherence in the end user, especially among younger populations. A viable ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2017 Category: Research Source Type: funding

Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44)
Funding Opportunity RFA-HD-18-102 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to invite SBIR applications to stimulate new and innovative multipurpose prevention technologies (MPTs) through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women. HIV and unintended pregnancy are two major public health problems affecting young women globally. Combination prevention modalities may be more desirable and lead to better adherence in the end user, especially among younger populations. A viable ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2017 Category: Research Source Type: funding

International Research Collaboration on Drug Abuse and Addiction Research (R21 Clinical Trial Optional)
Funding Opportunity PA-18-066 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of NIDA and where feasible should address NIDAs international scientific priority areas (http://www.drugabuse.gov/international/research-prio...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2017 Category: Research Source Type: funding

International Research Collaboration on Drug Abuse and Addiction Research (R03 Clinical Trial Optional)
Funding Opportunity PA-18-065 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of NIDA and where feasible should address NIDAs international scientific priority areas(http://www.drugabuse.gov/international/research-prior...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2017 Category: Research Source Type: funding

Trophoblast Differentiation and Function (R21 Clinical Trial Optional)
Funding Opportunity PA-18-047 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of trophoblast differentiation and function in relation to fertility and pregnancy, including the role of the immune system. It is anticipated that fundamental knowledge gained by this research will act as a solid foundation to hasten treatments for a number of placental-based pregnancy disorders, such as implantation failure, frequent pregnancy loss, preeclampsia, fetal growth restriction...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2017 Category: Research Source Type: funding

Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44)
Funding Opportunity RFA-HD-18-033 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to invite SBIR applications to stimulate new and innovative multipurpose prevention technologies (MPTs) through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women. HIV and unintended pregnancy are two major public health problems affecting young women globally. Combination prevention modalities may be more desirable and lead to better adherence in the end user, especially among younger populations. A viable ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2017 Category: Research Source Type: funding

Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42)
Funding Opportunity RFA-HD-18-034 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to invite STTR applications to stimulate new and innovative multipurpose prevention technologies (MPTs) through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women. HIV and unintended pregnancy are two major public health problems affecting young women globally. Combination prevention modalities may be more desirable and lead to better adherence in the end user, especially among younger populations. A viable ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2017 Category: Research Source Type: funding

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional)
Funding Opportunity PA-18-044 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to (1) promote preclinical, translational, clinical and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatments. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2017 Category: Research Source Type: funding

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)
Funding Opportunity PA-18-043 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to (1) promote preclinical, translational, clinical and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in the safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatment. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2017 Category: Research Source Type: funding

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional)
Funding Opportunity PA-18-038 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to (1) promote preclinical, translational, clinical and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatments. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2017 Category: Research Source Type: funding

Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21 Clinical Trial Optional)
Funding Opportunity PA-18-092 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate investigations including translational, epidemiologic and clinical studies and trials that improve the understanding, prevention and clinical outcomes of non-HIV infections transmitted from women to their offspring during pregnancy, labor and delivery, and breastfeeding. NICHD is committed to supporting research that will increase scientific understanding of and treatments for high-priority perinatal infections. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 2, 2017 Category: Research Source Type: funding

Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01 Clinical Trial Optional)
Funding Opportunity PA-18-031 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate investigations including translational, epidemiologic and clinical studies and trials that improve the understanding, prevention and clinical outcomes of non-HIV infections transmitted from women to their offspring during pregnancy, labor and delivery, and breastfeeding. NICHD is committed to supporting research that will increase scientific understanding of and treatments for high-priority perinatal infections. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 2, 2017 Category: Research Source Type: funding

Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)
Funding Opportunity PA-18-135 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications to improve health outcomes for women, infants and children, by stimulating interdisciplinary research focused on maternal nutrition and pre-pregnancy obesity. Maternal health significantly impacts not only the mother but also the intrauterine environment, and subsequently fetal development and the health of the newborn. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 1, 2017 Category: Research Source Type: funding

Challenge Competition: Improving Remote Monitoring of Pregnancy
A prize competition to support the development and testing of low-cost, scalable technology-based innovations to improve the ability of prenatal care providers to monitor the health and well being of pregnant women remotely, especially women who live in rural and medically-underserved areas who have limited access to on-site prenatal care. Geographic coverage: Nationwide -- Health Resources and Services Administration, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - October 25, 2017 Category: American Health Source Type: funding

Opioid Use Disorder in Pregnancy (R01)
Funding Opportunity RFA-HD-18-036 from the NIH Guide for Grants and Contracts. In this funding opportunity announcement (FOA), we invite prospective applicants to propose research addressing treatment of pregnant women with opioid use disorder and pharmacokinetic and pharmacodynamic studies of medications used for maternal treatment. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 25, 2017 Category: Research Source Type: funding

Next Generation Multipurpose Prevention Technologies (NGM) (R61/R33 Clinical Trial Optional)
The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative multipurpose prevention technologies (MPT) with rheological/biophysical properties and product user perceptions compatible with current long-acting reversible contraceptive (LARC) strategies (look, feel, effectiveness, safety and duration of action) for the dual purpose of preventing pregnancy and HIV infection in women. MPTs proposed for development must be dual indication and prevent pregnancy and HIV infection and have drug delivery systems (DDS) capable with sustained/extended release of both drugs. MPTs pro...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 12, 2017 Category: Research Source Type: funding

Pregnancy in Women with Disabilities (R01)
Funding Opportunity PA-17-452 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages research project grants (R01) investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with phy...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 3, 2017 Category: Research Source Type: funding

Pregnancy in Women with Disabilities (R03)
Funding Opportunity PA-17-451 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages small research project grants (R03) investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women wi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 3, 2017 Category: Research Source Type: funding

Medication Assisted Treatment Delivery for Pregnant Women with Substance Use Disorders Involving Prescription Opioids and/or Heroin
Grants for large, randomized controlled trials or well-justified observational studies that compare the effectiveness for maternal and neonatal outcomes of different models for comprehensive Opioid Use Disorder treatment delivery for pregnant and post-partum women with different levels of addiction severity. Geographic coverage: Nationwide -- Patient-Centered Outcomes Research Institute (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - July 12, 2017 Category: American Health Source Type: funding

COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia
Funding Opportunity ID: 292933 Opportunity Number: CDC-RFA-GH15-16300301SUPP17 Opportunity Title: COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in LiberiaOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.318Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: U...
Source: Grants.gov - April 1, 2017 Category: Research Tags: Health Source Type: funding

Identification of Target Peptide Sequences for Zika IgM Diagnostic Device
Funding Opportunity ID: 292882 Opportunity Number: RFA-FD-17-002 Opportunity Title: Identification of Target Peptide Sequences for Zika IgM Diagnostic DeviceOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: AgricultureConsumer ProtectionFood and NutritionCategory Explanation: CFDA Number(s): 93.103Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: The following organization is eligible to apply: PEPperPrint GmbHAge...
Source: Grants.gov - March 31, 2017 Category: Research Tags: Agriculture Consumer Protection Food and Nutrition Source Type: funding

Pan American Health Organization (PAHO) Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas (CK-1301-04SUPP2017)
Funding Opportunity ID: 292838 Opportunity Number: CDC-RFA-CK13-1301 Opportunity Title: Pan American Health Organization (PAHO) Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas (CK-1301-04SUPP2017)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.099Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Pan American Health Organization...
Source: Grants.gov - March 29, 2017 Category: Research Tags: Health Source Type: funding

Enhancing national STD/HIV prevention efforts by promoting holistic, comprehensive, and evidence-informed health and wellness approaches through strategic partnerships
Funding Opportunity ID: 292558 Opportunity Number: CDC-RFA-PS17-1708 Opportunity Title: Enhancing national STD/HIV prevention efforts by promoting holistic, comprehensive, and evidence-informed health and wellness approaches through strategic partnershipsOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.978Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility&...
Source: Grants.gov - March 18, 2017 Category: Research Tags: Health Source Type: funding

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03)
Funding Opportunity ID: 292195 Opportunity Number: PAR-17-188 Opportunity Title: Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthIncome Security and Social ServicesCategory Explanation: CFDA Number(s): 93.865Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federa...
Source: Grants.gov - March 3, 2017 Category: Research Tags: Health Income Security and Social Services Source Type: funding

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21)
Funding Opportunity ID: 292197 Opportunity Number: PAR-17-187 Opportunity Title: Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthIncome Security and Social ServicesCategory Explanation: CFDA Number(s): 93.17393.865Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (...
Source: Grants.gov - March 3, 2017 Category: Research Tags: Health Income Security and Social Services Source Type: funding